节点文献

南征教授应用加味消肾安汤治疗糖尿病肾病Ⅳ期的临床观察

Clinical observation on professor Nanzheng ’s application of Jiawei Xiaoshen’an Decoction in treating stage Ⅳ of diabetic nephropathy

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张静静刘乐张琦王新娜南征

【Author】 Zhang Jingjing;Liu Le;Zhang Qi;Wang Xinna;Nan Zheng;Changchun University of Chinese Medicine;Affiliated Hospital of Changchun University of Chinese Medicine;

【机构】 长春中医药大学长春中医药大学附属医院

【摘要】 目的观察南征教授应用加味消肾安汤治疗糖尿病肾病Ⅳ期的临床疗效。方法将120例糖尿病肾病Ⅳ期患者随机分为治疗组60例、对照组60例。剔除脱落病例后治疗组为57例、对照组为56例。治疗组在常规治疗基础上予加味消肾安汤加减治疗。对照组在常规治疗基础上予缬沙坦胶囊治疗。观察2组临床疗效,中医症状积分,24 h尿蛋白定量、糖化血红蛋白(HbA1c)及空腹血糖(FBG),安全指标。结果 2组临床疗效比较,治疗组57例中,显效15例,有效31例,无效11例,总有效46例,总有效率为80.70%;对照组56例中,显效9例,有效27例,无效20例,总有效36例,总有效率为64.29%。经秩和检验,Z=-2.043,P=0.041,P<0.05,说明治疗组疗效优于对照组。治疗后治疗组倦怠乏力、腰膝酸软、头晕耳鸣、纳差、水肿、尿浊、尿频积分较本组治疗前均降低(P<0.05)。对照组倦怠乏力、腰膝酸软、水肿、尿浊症状积分较本组治疗前均降低(P<0.05)。治疗组倦怠乏力、腰膝酸软、水肿、尿浊积分较对照组降低明显,治疗前后积分差值比较,差异有统计学意义(P<0.05)。治疗后治疗组24 h尿蛋白定量,HbA1c,FBG水平较本组治疗前均下降(P<0.05)。对照组24 h尿蛋白定量,FBG水平较本组治疗前均下降(P<0.05)。治疗组24 h尿蛋白定量,HbA1c,FBG较对照组下降明显,治疗前后差值比较,差异均有统计学意义(P<0.05),治疗组优于照组。结论加味消肾安汤治疗糖尿病肾病Ⅳ期具有较好的临床疗效。

【Abstract】 Objective To observe the clinical effect of professor Nan Zheng’s application of Jiawei Xiaoshen’an Decoction in the treatment of stage Ⅳ of diabetic nephropathy. Methods 120 patients with stage Ⅳ of diabetic nephropathy were randomly divided into treatment group and control group, with 60 cases in each group.There were 57 cases in the treatment group and 56 cases in the control group after removing the shedding cases. The treatment group was treated with Jiawei Xiaoshen’an Decoction on the basis of conventional treatment. The control group was treated with valsartan capsule on the basis of conventional treatment. The clinical efficacy, TCM symptom score, 24 h urine protein quantitation, HbA1 c and FBG and safety indicators were observed. Results The clinical efficacy of the two groups was compared. Among the 57 cases in the treatment group, 15 cases showed markedly effective, 31 cases were effective, 11 cases were ineffective, the total effective cases were 46 and the total effective rate was 80.70%. Among the 56 cases in the control group, 9 cases showed markedly effective, 27 cases were effective, 20 cases were ineffective, the total effective cases were 36 and the total effective rate was 64.29%. Rank sum test analysis showed Z=-2.043, P=0.041, P<0.05, which indicated the total efficacy rate of treatment group was superior to control group. After treatment, in the treatment group,the scores of fatigue, weakness of the waist, dizziness and tinnitus, anorexia, edema, turbidity and urinary frequency were decreased than those before treatment(P<0.05).In the control group, the scores of fatigue, weakness of the waist, edema, and turbidity were decreased than those before treatment(P<0.05).The scores of fatigue, weakness of the waist, edema, and turbidity in the treatment group were decreased than control group.The difference of the score before and after treatment was statistically significant(P<0.05).After treatment, in the treatment group, the 24 h urine protein quantitation, HbA1 c and FBG were decreased than those before treatment(P<0.05). In the control group, the 24 h urine protein and FBG were decreased than those before treatment(P<0.05). The 24 h urine protein quantitation, HbA1 c and FBG in the treatment group were decreased than control group.The difference was statistically significant(P<0.05).The treatment group was better than the control group. Conclusion Jiawei Xiaoshen’an Decoction has good effect in the treatment of stage Ⅳ of diabetic nephropathy.

【基金】 国家重点研发计划项目资助(No.2018YFC1704100),国家重点研发计划项目资助课题(No.2018YFC1704102)
  • 【文献出处】 现代中医临床 ,Modern Chinese Clinical Medicine , 编辑部邮箱 ,2019年06期
  • 【分类号】R259;R249
  • 【被引频次】7
  • 【下载频次】257
节点文献中: 

本文链接的文献网络图示:

本文的引文网络